Insulin Resistance and the Inflamed Brain

Imagine plugging in a phone that says it is charging, watching the little lightning bolt appear, and coming back an hour later to find the battery still at fourteen percent. The cable is connected. Power is flowing into the port. Something between the port and the battery is not passing the charge along. This is a reasonable way to picture what happens in a brain operating under insulin resistance: fuel is abundant in the bloodstream, the signal to use it is being sent loudly and repeatedly, and yet the cells that need the energy behave as though supply were short.

The mechanism starts peripherally. When the diet delivers a chronic excess of easily absorbed energy, particularly refined carbohydrate, the pancreas responds by releasing insulin again and again to keep blood glucose within range. Cells exposed to a constant signal do what any of us do with a notification that never stops: they turn down their sensitivity. Muscle, liver, and fat tissue respond less to the same amount of insulin, so the pancreas sends more. That compensation can keep fasting glucose looking respectable for years while circulating insulin climbs quietly in the background.

The brain is not a bystander in this. Insulin receptors sit on neurons and on glia, the support cells that maintain the neural environment, and insulin there functions less as a fuel switch and more as a neuromodulator. It supports synaptic plasticity, the physical remodeling of connections that underlies learning and adaptation. It participates in dopamine signaling, which governs motivation, anticipation, and the willingness to start something effortful. When insulin transport across the blood-brain barrier falters, these functions lose their regulator. The result is a peculiar mismatch: energy surplus in the body, relative energy scarcity in the tissue that consumes roughly a fifth of the body's fuel while occupying two percent of its mass.

A second dimension is immune. Adipose tissue, particularly abdominal fat, is metabolically active and secretes cytokines, signaling molecules that coordinate immune responses. Some cross the blood-brain barrier; others change its permeability. Inside the brain, microglia act as a resident maintenance and security team, pruning unused connections and clearing debris. Under sustained inflammatory signaling they shift into a defensive posture and stay there. Think of a building's security staff responding to a small fire that was extinguished weeks ago but never receiving the all-clear, so they keep the corridors sealed and the alarms armed. Useful vigilance becomes chronic obstruction, interfering with neurotransmitter synthesis and with the flexibility of synapses.

The third dimension is energetic wear. When glucose handling is impaired, mitochondria generate ATP less cleanly and produce more reactive oxygen species, the metabolic equivalent of a poorly tuned engine putting out extra exhaust. The brain's antioxidant defenses are modest relative to its workload, and this oxidative stress is implicated in both mood disorders and, over longer timescales, neurodegeneration. Layer these together and you get what researchers call allostatic load: systems that no longer reset to baseline after a challenge, leaving the person persistently activated and persistently depleted at the same time.

In working life this rarely announces itself as illness. It looks like being fine at nine in the morning and unable to hold a thread by two in the afternoon. It looks like reading the same paragraph three times. It looks like the projects you used to find interesting feeling like chores, which is easy to interpret as burnout or a character flaw rather than as blunted reward signaling. Irritability arrives before sadness. People describe the experience as a dimmer switch rather than a crash.

Three misreadings are worth naming. The first is assuming normal blood glucose means normal metabolism. Glucose is the last marker to move, held steady by rising insulin, which is why fasting insulin, triglycerides, and waist circumference tell a different story than a glucose reading alone. The second is treating this as a question of body size. Lean individuals can be insulin resistant and larger individuals can be metabolically healthy, and framing it morally obscures the biology. The third, and the most consequential, is assuming direction of causation. Depression reduces activity, disturbs sleep, and changes eating, all of which worsen metabolic health. Metabolic dysfunction, meanwhile, plausibly intensifies symptoms. Some psychiatric medications are genuinely effective and also adverse for metabolic markers, a tension that requires a clinician, not a self-directed decision. Nobody should stop or alter medication on the strength of a lesson like this one.

Here is the counterintuitive part. Inflammation in the brain does not feel like inflammation. There is no swelling to see, no heat, no ache. What a neuroinflammatory state produces is absence: absence of drive, absence of sharpness, absence of the emotional response you expected to have. The very quality that makes it easy to dismiss as a personality trait or a phase is what makes it worth investigating properly.